НовостиBenzingaWells Fargo Maintains Overweight on Helus Pharma, Raises Price Target to $22 Wells Fargo Maintains Overweight on Helus Pharma, Raises Price Target to $22 Benzinga 2026.10.22 15:26 (GMT+0) Открыть на Benzinga Другие новости